InvestSMART

Epsilon Healthcare Limited (ASX: EPN) - Share Price

- Current share price for EPN : $0.022

Epsilon Healthcare (EPN), an ASX-listed company, is an Australian based healthcare organisation. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacturing operation and pharmacy services.

EPN General Information +

ASX Code EPN
Website http://epsilonhealthcare.com.au
Industry/Sector Pharmaceuticals
Market Cap ($M) 8
EPN Share Price $0.022
Day High $0.023
Day Low $0.022
Last Close $0.022
EPN Share Price Movement - ( No change )
Prices as at 13:05, 22 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Epsilon Healthcare Limited (EPN) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Epsilon Healthcare Limited (EPN) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Epsilon Healthcare Limited (EPN) price-sensitive announcements

EPN - Quarterly Activities/Appendix 4C Cash Flow Report
Epsilon Healthcare Limited reported a significant increase in its financial performance fo
Epsilon Healthcare Limited (EPN)
30 Apr 2026 | 9:36 AM
EPN - Preliminary Final Report
The Preliminary Final Report for Epsilon Healthcare Limited for the year ended 31 December
Epsilon Healthcare Limited (EPN)
27 Feb 2026 | 5:22 PM
EPN - Epsilon Pharma signs manufacturing agreement with Puro NZ
Epsilon Healthcare Limited, through its subsidiary Epsilon Pharma Pty Ltd, has formed a ma
Epsilon Healthcare Limited (EPN)
5 Feb 2026 | 11:11 AM
EPN - Quarterly Activities/Appendix 4C Cash Flow Report
Epsilon Healthcare Limited (ASX: EPN) reported strong financial performance for the quarte
Epsilon Healthcare Limited (EPN)
28 Jan 2026 | 11:27 AM

Epsilon Healthcare Limited (EPN) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Epsilon Healthcare Limited (EPN)
ORDINARY FULLY PAID
 Health Care $9 Change in substantial holding 9 Jul 2026 8:20AM $0.022 $0.022 fallen by 0%
Epsilon Healthcare Limited (EPN)
ORDINARY FULLY PAID
 Health Care $9 Becoming a substantial holder 8 Jul 2026 4:24PM $0.022 $0.022 fallen by 0%
Epsilon Healthcare Limited (EPN)
ORDINARY FULLY PAID
 Health Care $9 Change of Director's Interest Notice - Zoe Hutchings 6 Jul 2026 6:58PM $0.022 $0.022 fallen by 0%
Epsilon Healthcare Limited (EPN)
ORDINARY FULLY PAID
 Health Care $9 Company Debt Arrangements - update 30 Jun 2026 5:48PM $0.022 $0.022 fallen by 0%
Epsilon Healthcare Limited (EPN)
ORDINARY FULLY PAID
 Health Care $9 Closure of small holding share sale facility 26 Jun 2026 4:49PM $0.022 $0.022 fallen by 0%
Epsilon Healthcare Limited (EPN)
ORDINARY FULLY PAID
 Health Care $9 Notification regarding unquoted securities - EPN 9 Jun 2026 9:50AM $0.023 $0.022 fallen by 4.35%

EPN Financial Summary

Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$2.05 -$0.50 -65.80% 0.00 0.00 0.00% 0.0%
2024A -$5.44 -$1.60 338.90% 0.00 0.00 0.00% 0.0%
2023A -$1.09 -$0.40 -93.10% 0.00 0.00 0.00% 0.0%

EPN Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Clarity Pharmaceuticals Ltd (CU6) $866M 0.3002 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Epsilon Healthcare Limited (EPN) $9M -0.6582 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Neuren Pharmaceuticals Limited (NEU) $2,149M -0.7857 0.0743 1.2000 72.8406 67.8000 30.8182 0.00% 0.00% 0.00%

EPN Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 4.40 0.00
Market 0.31 12.80 1.12 0.58
Sector 0.45 28.10 2.37 1.83

EPN Directors

Name Position Start Date
Mr Peter Giannopoulos Chief Executive Officer, Executive Director 11 Jun 2024
Ms Zoe Hutchings Non-Executive Director 11 Jun 2024
Mr Alan Preston Beasley Non-Executive Director, Non-Executive Chairman 29 Aug 2016

Epsilon Healthcare Limited (EPN) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
3 Jul 2026 HUTCHINGS, Zoe Buy Direct Shares 1,500,000 $0.020 $30,000.000
11 May 2026 BEASLEY, Alan Buy Direct Shares 100,000 $0.020 $2,010.000
7 May 2026 BEASLEY, Alan Buy Direct Shares 298,854 $0.021 $6,300.920

See all changes in directors' interest & trades for Epsilon Healthcare Limited (EPN) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EPN Management

Name Position
Daniel Kaplon Chief Financial Officer,Company Secretary

EPN Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Epsilon Healthcare Limited (EPN). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
35,828,878 (9.21%) Watercrest Asset Management Pty Ltd
21,250,000 (5.46%) Alexander Hotel Investments Pty Ltd

EPN Calendar of Events

Date Event
30 March 2027 Report (Annual)
26 February 2027 Report (Prelim)
15 December 2026 Report (Interim)
18 November 2026 Report (Annual)
06 October 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.